Loading...

Loading...

Analyzing New National Health Supplies Compendium Laws
By Juan Luis Serrano Leets - Mon, 01/23/2023 - 12:00
Juan Luis Serrano analyzes the new rules related to health supplies and their possible consequences in providing patients with access to innovation.
https://mexicobusiness.news/tag/sanchez-devanny
More Health
COFEPRIS Backlog: What Should Happen and What Can Companies Do?
By Juan Luis Serrano Leets - Thu, 10/06/2022 - 12:00
COFEPRIS is facing a severe backlog. Juan Serrano looks at three actions that can be taken by the authorities and industry to address the problem.
State of the Mexican Health Industry in 2022
By Miriam Bello - Mon, 09/05/2022 - 12:24
Advances and ongoing challenges have paved the way for the transformation of Mexico’s health system.
Pharmacoeconomics: Tool for Innovation and Access
By Sofía Garduño - Wed, 08/31/2022 - 16:32
Healthcare providers are embracing pharmacoeconomics to make better decisions, but the field must also improve.

Regulatory Clarity Key to the Provision of Health Services
By Miriam Bello - Wed, 08/10/2022 - 08:28
The Digital Health Law and other regulations need clarity to support the provision of health services, says Sanchez Devanny's Juan Luis Serrano.
Supreme Court Patent Decision Has Broad Implications
By Juan Luis Serrano Leets - Mon, 07/25/2022 - 09:00
Patent owners in Mexico are benefiting from a Supreme Court decision related to prosecution delays and compensation, writes Juan Luis Serrano.
Judicial Decision a First Victory for Equivalence Standards
By Juan Luis Serrano Leets - Wed, 04/20/2022 - 11:00
Court decision against COFEPRIS is a first step that could pave the way for more drugs and devices coming to Mexico, writes Juan Luis Serrano.
Digital Health Regulation in Mexico: Hits, Opportunities
By Alfonso Núñez - Wed, 02/16/2022 - 15:09
Industry experts discuss the need for regulation as well as best practices and benefits during the Digital Health Regulation panel of MHS 2022.
Pharmaceutical Industry Going Through Intense Therapy
By Mónica López - Tue, 02/16/2021 - 09:40
The pharmaceutical industry is going through intensive therapy, not as a patient but as an ally in supporting the health sector and its users
Pharmaceutical Industry at the Front Line of the Pandemic
By Andrea Villar - Wed, 01/27/2021 - 12:30
The pharmaceutical industry is going through intensive therapy, not as a patient but as an ally in supporting the health sector and its users